Equitec Proprietary Markets’s AbbVie ABBV Stock Holding History

Equitec Proprietary Markets’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$487K	Buy	4,541 +442	+11%	+$42.5K	0.13%	54
2020 Q3	$359K	Buy	+4,099	New	+$386K	0.27%	40
2016 Q1	–	Sell	-1,494	Closed	-$83.3K	–	147
2015 Q4	$89K	Hold	1,494	–	–	﹤0.01%	111
2015 Q3	$81K	Sell	1,494 -100,307	-99%	-$6.53M	﹤0.01%	127
2015 Q2	$6.84M	Buy	+101,801	New	+$6.65M	0.4%	17
2015 Q1	–	Sell	-14,384	Closed	-$941K	–	153
2014 Q4	$941K	Buy	+14,384	New	+$907K	0.04%	101

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Equitec Proprietary Markets's ABBV Position: Q4 2020 in Review

Equitec Proprietary Markets increased its AbbVie (ABBV) stake by 11% in Q4 2020, buying an estimated $42.5K and bringing the position to 4,541 shares worth $487K. The position accounts for 0.13% of the portfolio, ranked #54.

Equitec Proprietary Markets first reported a position in ABBV in Q4 2014 and has held it in 6 quarters since. The position peaked at $6.84M in Q2 2015. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Equitec Proprietary Markets held 4,541 shares of AbbVie worth $487K as of Q4 2020.
Equitec Proprietary Markets bought 442 AbbVie shares in Q4 2020, an estimated $42.5K.
AbbVie made up 0.13% of Equitec Proprietary Markets's portfolio in Q4 2020, its #54 holding.
Equitec Proprietary Markets first reported a position in AbbVie in Q4 2014 and has held it in 6 quarters since.
Equitec Proprietary Markets's AbbVie position peaked at $6.84M in Q2 2015.
2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Equitec Proprietary Markets's 13F filing for Q4 2020, filed 26 Jan 2021.